Clinical Trials Browser

Colonic Neoplasms

Pathologic Complete Response, Rectal Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Colonic Neoplasms

Carcinoma, Hepatocellular

Biliary Tract Neoplasms

Carcinoma, Hepatocellular

Locally Advanced Colorectal Carcinoma

Pancreatic Neoplasms

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Locally Advanced Rectal Cancer (LARC)

Stomach Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Esophageal Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Cholangiocarcinoma

Esophageal Neoplasms

Esophageal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Clinical Trials

TRIUNITE-08

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

G/GEJ

MODIFI-L

Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.

Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation

Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

TASK-01-RW

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

STELLARIII

A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis

CCGLC-001

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

ctDNA-guided Treatment of TKI Plus PD-1 Inhibitor for Advanced pMMR/MSS Colorectal Cancer

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer

Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

SILAR

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma